492 related articles for article (PubMed ID: 12360746)
1. [Gene therapy of Gaucher's and Fabry's diseases: current status and prospects].
Fabrega S; Lehn P
J Soc Biol; 2002; 196(2):175-81. PubMed ID: 12360746
[TBL] [Abstract][Full Text] [Related]
2. [Fabry's disease (alpha-galactosidase-A deficiency): recent therapeutic innovations].
Germain DP
J Soc Biol; 2002; 196(2):183-90. PubMed ID: 12360747
[TBL] [Abstract][Full Text] [Related]
3. Preselective gene therapy for Fabry disease.
Qin G; Takenaka T; Telsch K; Kelley L; Howard T; Levade T; Deans R; Howard BH; Malech HL; Brady RO; Medin JA
Proc Natl Acad Sci U S A; 2001 Mar; 98(6):3428-33. PubMed ID: 11248095
[TBL] [Abstract][Full Text] [Related]
4. Partial correction of the alpha-galactosidase A deficiency and reduction of glycolipid storage in Fabry mice using synthetic vectors.
Przybylska M; Wu IH; Zhao H; Ziegler RJ; Tousignant JD; Desnick RJ; Scheule RK; Cheng SH; Yew NS
J Gene Med; 2004 Jan; 6(1):85-92. PubMed ID: 14716680
[TBL] [Abstract][Full Text] [Related]
5. Correction of the enzyme deficiency in hematopoietic cells of Gaucher patients using a clinically acceptable retroviral supernatant transduction protocol.
Xu L; Stahl SK; Dave HP; Schiffmann R; Correll PH; Kessler S; Karlsson S
Exp Hematol; 1994 Feb; 22(2):223-30. PubMed ID: 8299741
[TBL] [Abstract][Full Text] [Related]
6. The presence of an autologous marrow stromal cell layer increases glucocerebrosidase gene transduction of long-term culture initiating cells (LTCICs) from the bone marrow of a patient with Gaucher disease.
Wells S; Malik P; Pensiero M; Kohn DB; Nolta JA
Gene Ther; 1995 Oct; 2(8):512-20. PubMed ID: 8593601
[TBL] [Abstract][Full Text] [Related]
7. Efficient correction of Fabry mice and patient cells mediated by lentiviral transduction of hematopoietic stem/progenitor cells.
Yoshimitsu M; Higuchi K; Ramsubir S; Nonaka T; Rasaiah VI; Siatskas C; Liang SB; Murray GJ; Brady RO; Medin JA
Gene Ther; 2007 Feb; 14(3):256-65. PubMed ID: 16929352
[TBL] [Abstract][Full Text] [Related]
8. Gene transfer and bone marrow transplantation with special reference to Gaucher's disease.
Karlsson S; Correll PH; Xu L
Bone Marrow Transplant; 1993; 11 Suppl 1():124-7. PubMed ID: 8448536
[TBL] [Abstract][Full Text] [Related]
9. Long-term expression of the human glucocerebrosidase gene in vivo after transplantation of bone-marrow-derived cells transformed with a lentivirus vector.
Kim EY; Hong YB; Lai Z; Cho YH; Brady RO; Jung SC
J Gene Med; 2005 Jul; 7(7):878-87. PubMed ID: 15712335
[TBL] [Abstract][Full Text] [Related]
10. Expression and secretion of human glucocerebrosidase mediated by recombinant lentivirus vectors in vitro and in vivo: implications for gene therapy of Gaucher disease.
Kim EY; Hong YB; Lai Z; Kim HJ; Cho YH; Brady RO; Jung SC
Biochem Biophys Res Commun; 2004 May; 318(2):381-90. PubMed ID: 15120612
[TBL] [Abstract][Full Text] [Related]
11. [Molecular diagnosis and gene therapy for Gaucher disease].
Ohashi T
Nihon Rinsho; 1993 Sep; 51(9):2300-7. PubMed ID: 8411706
[TBL] [Abstract][Full Text] [Related]
12. Long-term systemic therapy of Fabry disease in a knockout mouse by adeno-associated virus-mediated muscle-directed gene transfer.
Takahashi H; Hirai Y; Migita M; Seino Y; Fukuda Y; Sakuraba H; Kase R; Kobayashi T; Hashimoto Y; Shimada T
Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13777-82. PubMed ID: 12370426
[TBL] [Abstract][Full Text] [Related]
13. Transduction of CD34+ enriched cord blood and Gaucher bone marrow cells by a retroviral vector carrying the glucocerebrosidase gene.
Bahnson AB; Nimgaonkar M; Fei Y; Boggs SS; Robbins PD; Ohashi T; Dunigan J; Li J; Ball ED; Barranger JA
Gene Ther; 1994 May; 1(3):176-84. PubMed ID: 7584079
[TBL] [Abstract][Full Text] [Related]
14. AAV8-mediated expression of glucocerebrosidase ameliorates the storage pathology in the visceral organs of a mouse model of Gaucher disease.
McEachern KA; Nietupski JB; Chuang WL; Armentano D; Johnson J; Hutto E; Grabowski GA; Cheng SH; Marshall J
J Gene Med; 2006 Jun; 8(6):719-29. PubMed ID: 16528760
[TBL] [Abstract][Full Text] [Related]
15. Gene therapy for the lysosomal storage disorders.
Cabrera-Salazar MA; Novelli E; Barranger JA
Curr Opin Mol Ther; 2002 Aug; 4(4):349-58. PubMed ID: 12222873
[TBL] [Abstract][Full Text] [Related]
16. Transduction of mobilized peripheral blood CD34+ cells with the glucocerebrosidase cDNA.
Nimgaonkar MT; Bahnson AB; Boggs SS; Ball ED; Barranger JA
Gene Ther; 1994 May; 1(3):201-7. PubMed ID: 7584082
[TBL] [Abstract][Full Text] [Related]
17. Expression of human glucocerebrosidase in murine macrophages: identification of efficient retroviral vectors.
Freas-Lutz DL; Correll PH; Dougherty SF; Xu L; Pluznik DH; Karlsson S
Exp Hematol; 1994 Aug; 22(9):857-65. PubMed ID: 8062885
[TBL] [Abstract][Full Text] [Related]
18. Long-term enzyme correction and lipid reduction in multiple organs of primary and secondary transplanted Fabry mice receiving transduced bone marrow cells.
Takenaka T; Murray GJ; Qin G; Quirk JM; Ohshima T; Qasba P; Clark K; Kulkarni AB; Brady RO; Medin JA
Proc Natl Acad Sci U S A; 2000 Jun; 97(13):7515-20. PubMed ID: 10840053
[TBL] [Abstract][Full Text] [Related]
19. [Gaucher's and Fabry's diseases: biochemical and genetic aspects].
Caillaud C; Poenaru L
J Soc Biol; 2002; 196(2):135-40. PubMed ID: 12360742
[TBL] [Abstract][Full Text] [Related]
20. Animal model of Gaucher's disease from targeted disruption of the mouse glucocerebrosidase gene.
Tybulewicz VL; Tremblay ML; LaMarca ME; Willemsen R; Stubblefield BK; Winfield S; Zablocka B; Sidransky E; Martin BM; Huang SP
Nature; 1992 Jun; 357(6377):407-10. PubMed ID: 1594045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
